We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Miniaturized Microscope Shows Interior of Cells

By HospiMedica staff writers
Posted on 10 Apr 2002
A new miniaturized microscope is being developed that is 500 to 1,000 times smaller than anything in its class, according to scientists at the University of California at Berkeley (San Francisco, USA).

The new microscope is called micro confocal imaging array, or micro-CIA, which belongs to a group of devices known as bio-polymer-opto-electro-mechanical-systems, or BioPOEMS. More...
The Micro-CIA was invented by Luke P. Lee, assistant professor of bioengineering at UC Berkeley. BioPOEMS combine the world of optics with that of microelectromechanical systems (MEMS), for use in biologic applications. Dr. Lee foresees a future where doctors can view the DNA of tumor cells inside a patient as cancer drugs are delivered, or where antiterrorism units can identify single molecules of a biowarfare agent on site with a portable detector.

Dr. Lee and a colleague have captured an image of a plant cell with the microlens, which is smaller than the period at the end of this sentence. To test the accuracy of the microlens and scanner, they placed a cell sample taken from a flowering lily onto the platform of a conventional confocal microscope. Without moving the sample, they then captured a cross-sectional image of the cell wall, first with the traditional microscope and then with the microlens scanner. They found that the two images matched, showing that the microscopic lens could perform as well as a conventional one.

Dr. Lee says the size and sensitivity of the micro-CIA would allow technicians to quickly test even trace amounts of anthrax or smallpox in the field. The micro-CIA could also become a crucial part of a lab-on-a-chip, where researchers study genes and proteins.
"You could put this device on the tip of an endoscope that could be guided inside a cancer patient,” said Dr. Lee. "Doctors could then see how tumor cells behave in vivo. It would also be feasible to deliver drugs directly to the tumor cell, and then view how the cell responds to the drugs.”





Related Links:
Univ. of California

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.